Search

Search results

432 results found

Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease.

Papamichael, Konstantinos, Niels Vande Casteele, Bincy P Abraham, Timothy Ritter, Anjali Jain, and Adam S Cheifetz. 2023. “Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2978-2980.e2.

Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis.

Trivedi, Hirsh D, Emily W Lopes, Jeremy Glissen Brown, Shaan Dudani, Michelle Lai, Joseph D Feuerstein, and Theodore T Pierce. 2023. “Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.”. Journal of Clinical Gastroenterology 57 (6): 610-16.

Sarah Ballou, Ph.D.

Sarah Ballou, PhD is a clinical psychologist specializing in gastropsychology. Dr. Ballou is an Assistant Professor at Harvard Medical School and Director of GI Behavioral Health in the Division of Gastroenterology at Beth Israel Deaconess Medical Center. She also serves as Co‑Chair of the...

Loren G. Rabinowitz, M.D.

Dr. Loren Rabinowitz is an Assistant Professor of Medicine and founder/director of P2P IBD, a multidisciplinary preconception to postpartum clinic for patients with inflammatory bowel disease (IBD), and JOINT IBD, a multidisciplinary rheumatology/IBD Clinic at Beth Israel Deaconess Medical Center...